Oncocross Co., Ltd. (382150.KQ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenKRW 3,470.00

From 52W high−76.10%

Volume19371.00

Market capKRW 39.87B

P/E (TTM)—

P/S (TTM)100.8x

Div yield—

Key dataSep 18, 2026

Open

KRW 3,470.00

From 52W high

−76.10%

Volume

19371.00

Market cap

KRW 39.87B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−1.4x

P/E (TTM)

—

RSI (14)

46.7

MomentumView details →

1D Return

−1.34%

YTD Return

−65.03%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−1.4x

EV/Sales

38.0x

P/S (TTM)

100.8x

P/B (TTM)

2.9x

ProfitabilityView details →

Gross Margin

−296.55%

Net Margin

−1653.24%

EBITDA Margin

−2644.19%

ROE (TTM)

−48.21%

ROA (TTM)

−20.23%

Asset Turnover

0.01x

GrowthView details →

Revenue YoY

−61.91%

EPS YoY

+18.03%

FCF YoY

−25.96%

Revenue CAGR 3Y

+35.10%

EPS CAGR 3Y

−20.59%

EBITDA YoY

−94.18%

MomentumView details →

1D Return

−1.34%

YTD Return

−65.03%

1Y Return

−66.40%

RSI (14)

46.7

vs 50D SMA

−1.05%

vs 200D SMA

−50.22%

Capital & dividendView details →

Debt/Equity

0.02x

Current Ratio

1.44x

Quick Ratio

1.44x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

395.50M

Net Income (TTM)

−6.54B

Op. CF (TTM)

−7.16B

Latest newsMore news →

No recent news for 382150.KQ.

Similar companies

三生国健688336.SH Revolution Medicines, Inc.RVMD 3SBio Inc.01530.HK RemeGen Co., Ltd.09995.HK IMBdx461030.KQ 君实生物-U688180.SH Find similar companies →

Latest newsMore news →

No recent news for 382150.KQ.